TGM2 expression was also increased in MCF7 (breast cancer), DU145 (prostate cancer), and A549 (lung cancer) cell lines in response to two other EMT-inducers TNFα and EGF, demonstrating that increased TGM2 expression is consistently associated with the EMT process (32). Here, EGF is linked to prostate carcinoma.